5-chloro-N-[6-[2-(4-fluorophenyl)imidazo[1,2-a]pyridin-3-yl]imidazo[1,2-b]pyridazin-2-yl]pyridine-3-carboxamide
C25H15ClFN7O — CID 118538924
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-chloro-N-[6-[2-(4-fluorophenyl)imidazo[1,2-a]pyridin-3-yl]imidazo[1,2-b]pyridazin-2-yl]pyridine-3-carboxamide
5-chloro-N-[6-[2-(4-fluorophenyl)imidazo[1,2-a]pyridin-3-yl]imidazo[1,2-b]pyridazin-2-yl]pyridine-3-carboxamide (PubChem CID 118538924) has the molecular formula C25H15ClFN7O and a molecular weight of 483.89 g/mol. Its IUPAC name is 5-chloro-N-[6-[2-(4-fluorophenyl)imidazo[1,2-a]pyridin-3-yl]imidazo[1,2-b]pyridazin-2-yl]pyridine-3-carboxamide.
Molecular Properties
| Compound Name | 5-chloro-N-[6-[2-(4-fluorophenyl)imidazo[1,2-a]pyridin-3-yl]imidazo[1,2-b]pyridazin-2-yl]pyridine-3-carboxamide |
|---|---|
| PubChem CID | 118538924 |
| Molecular Formula | C25H15ClFN7O |
| Molecular Weight | 483.89 g/mol |
| Exact Mass | 483.10 |
| IUPAC Name | 5-chloro-N-[6-[2-(4-fluorophenyl)imidazo[1,2-a]pyridin-3-yl]imidazo[1,2-b]pyridazin-2-yl]pyridine-3-carboxamide |
| SMILES | O=C(Nc1cn2nc(-c3c(-c4ccc(F)cc4)nc4ccccn34)ccc2n1)c1cncc(Cl)c1 |
| InChI | InChI=1S/C25H15ClFN7O/c26-17-11-16(12-28-13-17)25(35)30-20-14-34-22(29-20)9-8-19(32-34)24-23(15-4-6-18(27)7-5-15)31-21-3-1-2-10-33(21)24/h1-14H,(H,30,35) |
| InChIKey | GWLVXJSQYOCWCY-UHFFFAOYSA-N |
| XLogP | 5.15 |
| TPSA | 89.48 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 483.89 |
| LogP ≤ 5 | 5.15 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118538924 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.